0001065544-16-000001.txt : 20160922 0001065544-16-000001.hdr.sgml : 20160922 20160922134856 ACCESSION NUMBER: 0001065544-16-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160922 DATE AS OF CHANGE: 20160922 EFFECTIVENESS DATE: 20160922 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SEQUELLA INC. CENTRAL INDEX KEY: 0001065544 IRS NUMBER: 522044703 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-271119 FILM NUMBER: 161897357 BUSINESS ADDRESS: STREET 1: 9610 MEDICAL CENTER DR STREET 2: SUITE 200 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-762-7776 MAIL ADDRESS: STREET 1: 9610 MEDICAL CENTER DR STREET 2: SUITE 200 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: SEQUELLA INC DATE OF NAME CHANGE: 19980708 D 1 primary_doc.xml X0707 D LIVE 0001065544 SEQUELLA INC. 9610 MEDICAL CENTER DR SUITE 200 ROCKVILLE MD MARYLAND 20850 301-762-7776 DELAWARE SEQUELLA INC Corporation true CAROL A. NACY 9610 MEDICAL CENTER DR SUITE 200 ROCKVILLE MD MARYLAND 20850 Executive Officer Director LEO EINCK 9610 MEDICAL CENTER DR SUITE 200 ROCKVILLE MD MARYLAND 20850 Executive Officer Director RONALD I. MELTZER 9610 MEDICAL CENTER DR SUITE 200 ROCKVILLE MD MARYLAND 20850 Director BRADLEY ROTTER 9610 MEDICAL CENTER DR SUITE 200 ROCKVILLE MD MARYLAND 20850 Director LAWRENCE MILLER 9610 MEDICAL CENTER DR SUITE 200 ROCKVILLE MD MARYLAND 20850 Executive Officer JOHN FRIEDMAN 9610 MEDICAL CENTER DR SUITE 200 ROCKVILLE MD MARYLAND 20850 Director PAIGE MACDONALD 9610 MEDICAL CENTER DR SUITE 200 ROCKVILLE MD MARYLAND 20850 Director Pharmaceuticals Decline to Disclose 06b false 2016-08-03 false true true true false 25000 LAMPOST CAPITAL, L.C. 43706 DAVID N. OLSON 4765634 7777 W. GLADES ROAD, SUITE 213 BOCA RATON FL FLORIDA 33434 CA CALIFORNIA FL FLORIDA NY NEW YORK WA WASHINGTON false 3006250 1724250 1282000 Offering amount includes warrant compensation noted in Item 15. false 9 15000 0 SALES COMMISSIONS PAID TO LAMPOST CAPITAL, L.C. INCLUDE $8,750 CASH FEE AND WARRANTS FOR COMMON STOCK SHARES WITH AGGREGATE EXERCISE PRICE OF $6,250. 0 false SEQUELLA INC. CAROL A. NACY CAROL A. NACY CEO 2016-09-21